ESPE Abstracts

ESPE Abstracts

Published by BioScientifica
Previous issue | Volume 97 | ESPE2023 | Next issue

61st Annual ESPE (ESPE 2023)

The Hague, Netherlands
21 Sept 2023 - 23 Sept 2023

Card image cap
The 61st ESPE Annual Meeting will now be taking place in The Hague, The Netherlands

Poster Category 1

Adrenals and HPA Axis

Table of contents
Next section
Bone, Growth Plate and Mineral Metabolism

hrp0097p1-1 | Adrenals and HPA Axis

Circulating miRNA profile in adrenarche

hrp0097p1-2 | Adrenals and HPA Axis

Metabolic effects of cortisol insufficiency are sex-depended in a zebrafish model of 21-hydroxylase deficiency

hrp0097p1-3 | Adrenals and HPA Axis

Acute Adrenal Insufficiency Related Adverse Events In Children With Congenital Adrenal Hyperplasia (CAH): Changes During The Period 2019-2022 In I-CAH

hrp0097p1-4 | Adrenals and HPA Axis

Major importance of genetic background in cortisol metabolism: Salivary diurnal glucocorticoid profiles in monozygotic twins with intra-twin birthweight-differences

hrp0097p1-5 | Adrenals and HPA Axis

Glucose profiles of children with classical congenital adrenal hyperplasia: lesson from continuous glucose monitoring

hrp0097p1-6 | Adrenals and HPA Axis

A retrospective analysis of children and youth with congenital adrenal hyperplasia treated with hydrocortisone modified-release hard capsules

hrp0097p1-7 | Adrenals and HPA Axis

The process of knowledge-making with a patient encounter – from education to negotiation of the way of treatment in patients with congenital adrenal hyperplasia (CAH).

hrp0097p1-8 | Adrenals and HPA Axis

Congenital Adrenal Hyperplasia (CAH): Situation and Possibility to Develop a Newborn Screening in Indonesia -- An Exploratory Study

hrp0097p1-9 | Adrenals and HPA Axis

The @MATES4Kids Movement: Reducing Preventable Mortality Associated with Congenital Adrenal Hyperplasia (CAH) by 30% by 2030

hrp0097p1-10 | Adrenals and HPA Axis

Endocrinological, genetic and immunological features of a long-term survivor with MIRAGE syndrome

hrp0097p1-11 | Adrenals and HPA Axis

Girls with Premature Adrenarche but not SGA Reach Their Target Height

hrp0097p1-12 | Adrenals and HPA Axis

Growth and Metabolic Syndrome (MetS) Criteria in children with Classic Congenital Adrenal Hyperplasia (CAH) treated with corticosteroids (CS) versus normal obese children.

hrp0097p1-13 | Adrenals and HPA Axis

Epidemiology and causes of primary adrenal insufficiency in children: A population-based study

hrp0097p1-14 | Adrenals and HPA Axis

Use of Aromatase inhibitors to improve height outcomes in children with Congenital Adrenal Hyperplasia due to 21 hydroxylase deficiency

hrp0097p1-15 | Adrenals and HPA Axis

Abstract unavailable

hrp0097p1-200 | Adrenals and HPA Axis

Evaluation of chromatin remodeling factors ATRX and DAXX and telomeres in pediatric adrenocortical tumors.

hrp0097p1-201 | Adrenals and HPA Axis

Molecular characterization of TNXA/TNXB chimeras in cases carrying deletion of the CYP21A2 gene: High incidence of chimeras identified.

hrp0097p1-202 | Adrenals and HPA Axis

Increased adiposity and insulin resistance negatively affect growth in pre-pubertal heterozygote carriers of 21-Hydroxylase deficiency

hrp0097p1-203 | Adrenals and HPA Axis

Adrenal insufficiency due to bioinactive ACTH caused by novel POMC variants

hrp0097p1-204 | Adrenals and HPA Axis

Longitudinal Changes in Serum DLK1 Concentrations During Minipuberty in Healthy Infant Girls; Association to Changes in Linear Growth and Fat Mass

hrp0097p1-205 | Adrenals and HPA Axis

Effects of hyperandrogenism on psychological perception and quality of life in patients with non-classical congenital adrenal hyperplasia

hrp0097p1-206 | Adrenals and HPA Axis

Adrenal insufficiency is not a common cause of hypoglycemia in children

hrp0097p1-207 | Adrenals and HPA Axis

Health-Related Quality of Life in Children with Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis

hrp0097p1-208 | Adrenals and HPA Axis

Genotype-Specific Cortisol Reserve in a Cohort of Subjects with Non-Classic Congenital Adrenal Hyperplasia (NCCAH)

hrp0097p1-209 | Adrenals and HPA Axis

Successful transition in Congenital Adrenal Hyperplasia - A single centre experience over 20 years

hrp0097p1-210 | Adrenals and HPA Axis

Change of Thyroid Volume in the Treatment of Congenital Primary Hypothyroidism

hrp0097p1-211 | Adrenals and HPA Axis

Salivary 11-oxygenated 19-carbon steroids in children with congenital adrenal hyperplasia and Addison's disease compared to healthy children

hrp0097p1-212 | Adrenals and HPA Axis

Features of allel variants of congenital adrenal hyperplasia in kazakhstan children of different ethnic groups

hrp0097p1-399 | Adrenals and HPA Axis

Transcriptome profiling evaluation of pediatric adrenocortical tumors (pACT) reveals a favorable-prognosis transcription signature and potential therapeutic targets.

hrp0097p1-400 | Adrenals and HPA Axis

11-oxygenated androgens as biomarkers in congenital adrenal hyperplasia: reference intervals for children

hrp0097p1-401 | Adrenals and HPA Axis

Impact of Newborn Screening for Congenital Adrenal Hyperplasia (CAH) on Adult Height: Data from the CAH Registry of the German Society for Pediatric and Adolescent Endocrinology and Diabetology (DGPAED).

hrp0097p1-402 | Adrenals and HPA Axis

Micronodular bilateral adrenal hyperplasia: about 2 cases in early childhood

hrp0097p1-403 | Adrenals and HPA Axis

Pediatric Cushing`s disease due to somatic USP8 mutations

hrp0097p1-404 | Adrenals and HPA Axis

Nephrocalcinosis: an emerging issue in children with Congenital Adrenal Hyperplasia

hrp0097p1-405 | Adrenals and HPA Axis

Multicenter study on clinical, biochemical and ultrasonographic characteristics, therapeutic management and outcome of TART in males with congenital adrenal hyperplasia.

hrp0097p1-406 | Adrenals and HPA Axis

Congenital adrenal hyperplasia due to 11 β-hydroxylase deficiency: Clinical, Biochemical and Genetic characteristics

hrp0097p1-407 | Adrenals and HPA Axis

17OHP levels to diagnose Non-Classic Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency (NC-CAH) in children with precocious pubarche

hrp0097p1-408 | Adrenals and HPA Axis

Primary Adrenal Insufficiency in Children: Genetic and Clinical Characterization of a Large Cohort in Thailand

hrp0097p1-409 | Adrenals and HPA Axis

Hydrocortisone (HC) versus Prednisone(P) Therapy in treating Children with Classic Congenital Adrenal Hyperplasia (CAH): Impact on statural growth weight gain and metabolic criteria

hrp0097p1-410 | Adrenals and HPA Axis

Patient education for management of sick day episodes in adrenal insufficiency: A systematic review of structured education and online patient resources

Published by BioScientifica

ESPE Abstracts

© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more